Cardiovascular and metabolic diseases including obesity remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programs, said Chris Boshoff, MD, PhD, Chief Scientific Officer and President, Research and Development at Pfizer
Several meta-analyses found that Gln supplementation can reduce the mortality, complication rate, and total length of hospital stay for patients with severe pancreatitis
Its unique composition effectively inhibits bacterial growth
Melanoma Res 2005
On Thursday, Janelle addressed the controversy and apologized if fans felt deceived by her confession
Ill give it one more month, provide another update